A device and system for treating pollutants in biomedical tuberculosis wards

Abstract

The present invention relates to the technical field of pollutant disinfection and treatment, and in particular to a device and system for treating pollutants in biomedical tuberculosis wards. The device comprises: a breathing mask, a system for treating pollutants in biomedical tuberculosis wards, an exhaled gas transmission pipeline, an ultraviolet disinfection chamber, a gas transmission pipeline, an atomization pipeline, a drug storage tank, a metering pump, an ultrasonic atomizer, a first plate-shaped gas guide plate, a plasma disinfection chamber, a second plate-shaped gas guide plate, a third plate-shaped gas guide plate, an exhaust port, a wavy gas guide plate, a wavy gas guide plate, a robotic arm, a drug delivery pipeline, a discharge electrode and an insulating medium, and a heating wire. The present invention improves the disinfection and treatment effects of tuberculosis and reduces the risk of infection.

Description

Technical Field

[0001] The present invention relates to the technical field of pollutant disinfection and treatment, and in particular to a device and system for treating pollutants in biomedical tuberculosis wards. Background Art

[0002] Tuberculosis bacteria are mainly transmitted through droplets. The gas exhaled by patients contains a large number of bacteria. The tuberculosis ward is a high-risk environment for infection. Medical staff and patients have frequent contact. Manually wearing masks will increase the chance of cross-infection. The atomization device can produce atomized particles with appropriate humidity to moisten the respiratory tract, dilute sputum, relieve patients' discomfort, prevent the spread of bacteria in the ward, and protect the health of other patients and medical staff in the ward.

[0003] Chinese Patent Publication No. CN107185024B discloses a saliva processing device for a tuberculosis ward, comprising a cabinet, a saliva processing unit, and a storage chamber. By connecting a saliva collection box to a disinfection chamber and a separation chamber, the patient can immediately disinfect the saliva collection box and the saliva therein after spitting saliva into the saliva collection box. The disinfection chamber then separates the treated waste liquid in the separation chamber, separating the saliva and disinfectant for subsequent discharge and disposal. Furthermore, a saliva collection hopper is provided on the cabinet, which is convenient for bedridden patients. This solution only processes the patient's saliva and does not provide treatment for the patient, making it difficult to improve disinfection and treatment effectiveness, while also failing to reduce the risk of infection. Summary of the Invention

[0004] To this end, the present invention provides a device for treating pollutants in biomedical tuberculosis wards, so as to overcome the problems in the prior art of low disinfection effect of tuberculosis wards and low treatment effect of tuberculosis patients, as well as high risk of infection for medical staff.

[0005] To achieve the above-mentioned object, the present invention provides a device for treating pollutants in a biomedical tuberculosis ward, the device comprising:

[0006] A breathing mask connected to a telescopic arm for collecting gas exhaled by the patient and performing aerosol treatment on the patient;

[0007] A system for treating pollutants in a biomedical tuberculosis ward, which is connected to a device for treating pollutants in a biomedical tuberculosis ward and is used to control the device for treating pollutants in the biomedical tuberculosis ward;

[0008] An exhaled gas transmission pipeline is connected to the breathing mask and the ultraviolet disinfection chamber and is used to transmit the patient's exhaled gas to the ultraviolet disinfection chamber;

[0009] The ultraviolet disinfection chamber is externally connected to the exhaled gas transmission pipeline, the gas transmission pipeline and the plasma disinfection chamber, and is internally provided with a left wavy gas guide plate and a right wavy gas guide plate for ultraviolet disinfection of the patient's exhaled gas;

[0010] A gas transmission pipeline is connected to the ultraviolet disinfection chamber and the plasma disinfection chamber, and is used to transmit the exhaust gas from the plasma disinfection chamber that does not meet the emission standards to the ultraviolet disinfection chamber;

[0011] an atomization pipe connected to the breathing mask and the ultrasonic nebulizer, and used for transmitting the atomized medicine in the ultrasonic nebulizer to the breathing mask;

[0012] a drug storage tank connected to the metering pump and used to store therapeutic drugs;

[0013] a metering pump connected to the drug storage tank and connected to the ultrasonic nebulizer through a drug delivery pipeline, for transferring the therapeutic drug from the drug storage tank to the ultrasonic nebulizer;

[0014] An ultrasonic nebulizer is connected to a metering pump via a drug delivery pipe and to a breathing mask via an atomization pipe, and is used to atomize therapeutic drugs to obtain aerosolized drugs;

[0015] a first plate-shaped gas guide plate, which is installed in the plasma disinfection chamber and is used to drain the patient's exhaled gas entering the plasma disinfection chamber;

[0016] The plasma disinfection chamber is connected to the ultraviolet disinfection chamber and is used to perform plasma disinfection on the patient's exhaled gas;

[0017] a second plate-shaped gas guide plate, which is installed in the plasma disinfection chamber and is used to drain the patient's exhaled gas entering the plasma disinfection chamber;

[0018] a third plate-shaped gas guide plate, which is installed in the plasma disinfection chamber and is used to drain the patient's exhaled gas entering the plasma disinfection chamber;

[0019] An exhaust port, connected to the plasma disinfection chamber, for discharging gas that meets emission standards;

[0020] The left wavy gas deflector is installed in the ultraviolet disinfection chamber and is used to drain the patient's exhaled gas in the ultraviolet disinfection chamber;

[0021] The right wavy gas deflector is installed in the ultraviolet disinfection chamber and is used to drain the patient's exhaled gas in the ultraviolet disinfection chamber;

[0022] a robotic arm connected to the breathing mask and used to control the breathing mask to reach the patient's face;

[0023] a drug delivery pipeline connected to a metering pump and an ultrasonic nebulizer for delivering therapeutic drugs;

[0024] Discharge electrodes and insulating medium, which are installed in the ultraviolet disinfection chamber, are used to generate low-temperature plasma, prevent short circuits between electrodes, and adjust electric field distribution;

[0025] The heating wire is installed in the ultrasonic nebulizer and is used to regulate the temperature of the atomized medicine.

[0026] In another aspect, the present invention further provides a system for treating pollutants in a biomedical tuberculosis ward, the system comprising:

[0027] An acquisition module collects operating data of the processing device;

[0028] a disinfection control module for adjusting the plasma disinfection chamber according to the disinfection power of the plasma disinfection chamber and a preset minimum disinfection power and a preset maximum disinfection power; calibrating the adjusted plasma disinfection chamber according to the concentration of pathogens entering the plasma disinfection chamber and a preset minimum pathogen concentration and a preset maximum pathogen concentration; optimizing the process of the calibrated and adjusted plasma disinfection chamber according to the patient's coughing frequency and a preset patient coughing frequency; adjusting the metering pump according to the concentration of each therapeutic drug and a preset therapeutic drug concentration; correcting the preset therapeutic drug concentration according to the patient's drug acceptance and a preset acceptance; and regulating the heating wire according to the atomized drug temperature and a preset minimum atomized drug temperature and a preset maximum atomized drug temperature;

[0029] A treatment feedback module is used to output the concentration of pathogens entering the plasma disinfection chamber after a preset treatment time and the preset concentration of pathogens recovered by the patient in the exhaled air;

[0030] The gas exhaust module is used to control the exhaust port according to the pathogen concentration of the gas exhausted from the plasma disinfection chamber and the preset pathogen concentration of the gas exhausted.

[0031] Furthermore, the disinfection control module compares the disinfection power P of the plasma disinfection chamber with the preset minimum disinfection power P1 and the preset maximum disinfection power P2, judges the size of the disinfection power according to the comparison result, and adjusts the plasma disinfection chamber according to the judgment result, wherein:

[0032] P1=15W,P2=25W;

[0033] When P1≤P≤P2, it is determined that the plasma disinfection power is normal, and the plasma disinfection chamber is not controlled;

[0034] When P<P1, it is determined that the plasma disinfection power is too low, and the voltage U of the discharge electrode in the plasma disinfection chamber is adjusted, wherein the original voltage is U0, and the adjusted voltage is Up0min, Up0min=U0×(1+e （P / P1） );

[0035] When P>P2, it is determined that the plasma disinfection power is too high, and the voltage U of the discharge electrode in the plasma disinfection chamber is adjusted, wherein the original voltage is U0, and the adjusted voltage is Up0max, Up0max=U0×(1-e （P / P1） ).

[0036] Furthermore, the disinfection control module compares the pathogen concentration L entering the plasma disinfection chamber with the preset minimum pathogen concentration L1 and the preset maximum pathogen concentration L2, judges the concentration of the pathogen entering the plasma disinfection chamber based on the comparison result, and calibrates the adjusted plasma disinfection chamber based on the judgment result, wherein:

[0037] L1=32 CFU / m 3 , L2=128CFU / m 3 ;

[0038] When L1≤L≤L2, it is determined that the concentration of the pathogens entering the plasma disinfection chamber is normal, and the adjusted plasma disinfection chamber is not calibrated;

[0039] When L<L1, it is determined that the concentration of pathogens entering the plasma disinfection chamber is low, and the adjusted plasma disinfection chamber is not corrected;

[0040] When L>L2, it is determined that the concentration of pathogens entering the plasma disinfection chamber is high. The adjusted plasma disinfection chamber is corrected by increasing the disinfection power P of the plasma disinfection chamber. The disinfection power of the corrected plasma disinfection chamber is set to PL, PL=0.82+e 0.5×[(L-L2)+18] ×P.

[0041] Furthermore, the disinfection control module compares the patient's cough frequency K with a preset patient cough frequency K0, determines the relationship between the patient's cough frequency and the concentration of pathogens entering the plasma disinfection chamber based on the comparison result, and optimizes the process of the calibrated and adjusted plasma disinfection chamber based on the judgment result, wherein:

[0042] When K≤K0, the relationship between the patient's cough frequency and the pathogen concentration is determined to be low frequency, which does not affect the concentration of pathogens entering the plasma disinfection chamber, and the process of the plasma disinfection chamber after calibration and adjustment is not optimized;

[0043] When K>K0, the relationship between the patient's cough frequency and the pathogen concentration is determined to be high frequency, the pathogen concentration entering the plasma disinfection chamber is increased, and the pathogen concentration L in the plasma disinfection chamber after correction and adjustment is optimized. The optimized pathogen concentration is set as Lk, Lk=[0.77+e 0.62×[(K-K0)+3] ]×L.

[0044] Furthermore, the disinfection control module compares each therapeutic drug concentration Y1, Y2, Y3, ..., Yn with the preset therapeutic drug concentrations Y01, Y02, Y03, ... Y0n, judges whether each therapeutic drug concentration meets the standard based on the comparison results, and adjusts the metering pump based on the judgment results, wherein:

[0045] When Y1<Y10, it is determined that the concentration of the therapeutic drug is too low, and the volume Vy1 of the therapeutic drug delivered each time by the metering pump is adjusted to Vminy1, where Vminy1=1.5×Vy1;

[0046] When Y1=Y10, the concentration of the therapeutic drug is determined to be appropriate and the metering pump is not adjusted;

[0047] When Y1>Y10, it is determined that the concentration of the therapeutic drug is too high, and the volume Vy1 of the therapeutic drug delivered each time by the metering pump is adjusted to Vmaxy1, where Vmaxy1=0.5×Vy1;

[0048] When Y2<Y20, it is determined that the concentration of the therapeutic drug is too low, and the volume Vy2 of the therapeutic drug delivered each time by the metering pump is adjusted to Vminy2, where Vminy2=1.5×Vy2;

[0049] When Y2=Y20, the concentration of the therapeutic drug is determined to be appropriate and the metering pump is not adjusted;

[0050] When Y2>Y20, it is determined that the concentration of the therapeutic drug is too high, and the volume Vy2 of the therapeutic drug delivered each time by the metering pump is adjusted to Vmaxy2, where Vmaxy2=0.5×Vy2;

[0051] When Y3<Y30, it is determined that the concentration of the therapeutic drug is too low, and the volume Vy3 of the therapeutic drug delivered each time by the metering pump is adjusted to Vminy3, where Vminy3=1.5×Vy3;

[0052] When Y3=Y30, the concentration of the therapeutic drug is determined to be appropriate and the metering pump is not adjusted;

[0053] When Y3>Y30, it is determined that the concentration of the therapeutic drug is too high, and the volume Vy3 of the therapeutic drug delivered each time by the metering pump is adjusted to Vmaxy3, where Vmaxy3=0.5×Vy3;

[0054] …

[0055] When Yn<Yn0, it is determined that the concentration of the therapeutic drug is too low, and the volume Vyn of the therapeutic drug delivered each time by the metering pump is adjusted to Vminyn, where Vminyn=1.5×Vyn;

[0056] When Yn=Yn0, the concentration of the therapeutic drug is determined to be appropriate and the metering pump is not adjusted;

[0057] When Yn>Yn0, it is determined that the concentration of the therapeutic drug is too high, and the volume Vyn of the therapeutic drug delivered each time by the metering pump is adjusted to Vmaxyn, where Vmaxyn=0.5×Vyn.

[0058] Furthermore, the disinfection control module compares the patient's drug acceptance J with the preset acceptance J0, judges the patient's treatment effect based on the comparison result, and corrects the preset concentrations of each therapeutic drug based on the judgment result, wherein:

[0059] When J≥J0, the patient's treatment effect is determined to be satisfactory, and no correction is made to the preset concentrations of the therapeutic drugs;

[0060] When J<J0, the patient's treatment effect is determined to be substandard, and the preset concentrations of each therapeutic drug are corrected. The corrected preset concentrations of each therapeutic drug are set as Yj01, Yj02, Yj03, ..., Yj0n, and the calculation formulas are Yj01=1.68e J-J0 +2J+Y01、Yj02=1.68e J-J0 +2J+Y02、Yj03=1.68e J-J0 +2J+Y03、……、Yj0n=1.68e J-J0 +2J+Y0n.

[0061] Furthermore, the disinfection control module compares the atomized drug temperature W with the preset minimum atomized drug temperature W1 and the preset maximum atomized drug temperature W2, judges the credibility of the patient's drug acceptance based on the comparison results, and regulates the heating wire based on the judgment results, wherein:

[0062] When W1≤W≤W2, the credibility of the patient's drug acceptance is determined to be up to standard, and the heating wire is not regulated;

[0063] When W<W1, it is determined that the credibility of the patient's drug acceptance does not meet the standard, and the heating wire is adjusted to increase the atomized drug temperature W until the credibility of the patient's drug acceptance meets the standard;

[0064] When W>W2, it is determined that the reliability of the patient's drug acceptance does not meet the standard, and the heating wire is regulated to reduce the atomized drug temperature W until the reliability of the patient's drug acceptance meets the standard.

[0065] Furthermore, the treatment feedback module compares the pathogen concentration L0 entering the plasma disinfection chamber after the preset treatment time with the preset patient recovery exhaled pathogen concentration L03, judges the actual treatment situation of the patient based on the comparison result, and outputs the judgment result, wherein:

[0066] When L=0, the actual treatment situation of the patient is judged to be that the actual exhaled pathogen concentration of the patient is 0, the patient has been successfully cured, and the output is the end of treatment;

[0067] When L≤L03, the actual treatment situation of the patient is judged to be that the concentration of pathogens actually exhaled by the patient is reduced, the patient's condition is alleviated, and the output is to maintain treatment;

[0068] When L>L03, it is determined that the actual treatment situation of the patient is that the concentration of pathogens actually exhaled by the patient increases and the patient's condition worsens. The output is to adjust the time the patient wears the breathing mask. The original time the patient wears the breathing mask is set to T0, and the adjusted time the patient wears the breathing mask is T0`, T0`=T0+(L-L03) / L.

[0069] Furthermore, the gas exhaust module compares the pathogen concentration Lp of the gas discharged from the plasma disinfection chamber with the preset pathogen concentration Lp0 of the gas discharged, judges whether the pathogen concentration Lp of the gas discharged from the plasma disinfection chamber meets the emission standard based on the comparison result, and controls the exhaust port based on the judgment result, wherein:

[0070] When Lp≤Lp0, it is determined that the pathogen concentration Lp of the gas discharged from the plasma disinfection chamber reaches the emission standard, and the gas emission module controls the exhaust port to open to discharge the gas discharged from the plasma disinfection chamber;

[0071] When Lp>Lp0, it is determined that the pathogen concentration Lp of the plasma disinfection chamber exhaust gas does not meet the emission standard, and the gas exhaust module controls the exhaust port to be closed, and re-transmits the plasma disinfection chamber exhaust gas to the ultraviolet disinfection chamber for disinfection.

[0072] Compared with the prior art, the beneficial effect of the present invention is that the device is applied in the tuberculosis ward, and the device collects the patient's exhaled gas through the breathing mask, the telescopic arm and the gas transmission pipeline, and transmits it to the ultraviolet disinfection chamber. The left wavy gas guide plate and the right wavy gas guide plate in the ultraviolet disinfection chamber guide the flow of the patient's exhaled gas to ensure that the gas is fully exposed to ultraviolet rays. At the same time, the discharge electrode and the insulating medium in the ultraviolet disinfection chamber generate low-temperature plasma to enhance the disinfection effect. The gas disinfected by the ultraviolet disinfection chamber enters the plasma disinfection chamber through the gas transmission pipeline. The first plate-shaped gas guide plate and the second plate-shaped gas guide plate in the plasma disinfection chamber The body guide plate and the third plate-shaped gas guide plate guide the flow of gas disinfected by the ultraviolet disinfection chamber, ensuring that the gas disinfected by the ultraviolet disinfection chamber is fully exposed to the plasma for further disinfection. The gas that meets the emission standards and is disinfected by the ultraviolet disinfection chamber and the plasma disinfection chamber is discharged through the exhaust port. The device stores therapeutic drugs through a drug storage tank. At the same time, the metering pump transmits the therapeutic drugs to the ultrasonic nebulizer through a drug delivery pipeline. The heating wire in the ultrasonic nebulizer regulates the temperature of the therapeutic drugs to ensure the atomization effect. The ultrasonic nebulizer transmits the atomized therapeutic drugs to the breathing mask through the atomization pipeline to perform atomization treatment on the patient. The device collects the patient's exhaled gas through a breathing mask to ensure that the gas does not diffuse into the environment, and provides aerosol treatment to deliver medicine to the patient. The device safely transmits the patient's exhaled gas to the ultraviolet disinfection chamber through the exhaled gas transmission pipeline to prevent gas leakage. The device performs ultraviolet disinfection through the ultraviolet disinfection chamber to effectively kill pathogens in the exhaled gas, and ensures that the gas is evenly exposed to ultraviolet rays through the left wavy gas deflector and the right wavy gas deflector to improve the disinfection efficiency. The device performs plasma disinfection through the plasma disinfection chamber to further kill pathogens that have not been completely treated by ultraviolet rays, and through the plate-shaped gas deflector The plate ensures that the gas is evenly distributed in the cavity to improve the disinfection effect. The device atomizes the medicine through an ultrasonic nebulizer to facilitate patient inhalation and improve the drug absorption efficiency. The device controls the drug delivery amount through a metering pump to ensure the treatment effect. The device stores therapeutic drugs through a drug storage tank to ensure drug stability and effectiveness. The device discharges standard gas through an exhaust port to ensure environmental safety. The device generates low-temperature plasma through discharge electrodes and insulating media to enhance the ultraviolet disinfection effect and prevent electrode short circuit to ensure safe operation of the equipment. The device regulates the drug temperature through a heating wire to ensure the atomization effect and patient comfort.

[0073] In particular, the system uses the acquisition module to collect the operating data of the processing device in real time, and provides data support for the disinfection control module, the treatment feedback module and the gas emission module to ensure dynamic monitoring of the disinfection and treatment process. The system adjusts the disinfection power, corrects the disinfection power, optimizes the disinfection process, adjusts the therapeutic drug delivery amount of the metering pump, corrects the drug concentration setting, and regulates the working state of the heating wire through the disinfection control module to optimize the treatment process according to the specific situation of the patient, improve the treatment effect, and thus ensure the maximization of the disinfection effect and the treatment effect. The system uses the treatment feedback module to evaluate the treatment effect according to the changes in the pathogen concentration, dynamically adjust the treatment process, and realize precision medicine. The system uses the gas emission module to ensure that the pathogen concentration in the exhaust gas meets the safety standards to avoid environmental pollution.

[0074] In particular, the acquisition module covers data on disinfection, treatment and discharge, ensuring comprehensive monitoring of system operation and improving operational efficiency.

[0075] In particular, the disinfection control module monitors the disinfection power P and compares it with the preset power range, automatically adjusts the voltage of the discharge electrode, ensures that the disinfection process is carried out within a safe and effective power range, prevents insufficient disinfection effect or equipment damage, judges the disinfection needs by monitoring the pathogen concentration L, and automatically adjusts the disinfection power to keep the indoor air quality within a safe range, thereby effectively controlling the infection risk, and combines the patient's cough frequency K to judge the impact of coughing on the pathogen concentration, further optimizes the disinfection process to cope with potential increases in pathogen concentrations, and ensures that the disinfection effect is sustained and effective. By comparing the actual drug concentration with the preset standard concentration, the delivery volume of the metering pump is automatically adjusted to ensure that the drug concentration is always within the optimal treatment range, thereby improving the treatment effect. According to the patient's drug acceptance J, the drug concentration is adjusted to provide a personalized treatment plan to achieve the best treatment effect. By adjusting the temperature of the atomized drug to ensure that it is within the preset temperature range, the drug acceptance and treatment comfort are improved, which helps to improve the patient's treatment quality and safety.

[0076] In particular, the treatment feedback module determines the patient's recovery status by real-time monitoring of pathogen concentration, ensures the effectiveness of treatment, and adjusts the wearing time of the respiratory mask to prevent the disease from worsening and ensure the safety of the patient.

[0077] In particular, the gas emission module ensures that only gases that meet safety standards are emitted by real-time monitoring of pathogen concentrations in the exhaust gas, thereby reducing potential risks to the environment and human health. BRIEF DESCRIPTION OF THE DRAWINGS

[0078] Figure 1 This is a schematic structural diagram of a device for treating pollutants in a biomedical tuberculosis ward according to this embodiment;

[0079] Figure 2 Schematic diagram of the structure of the system for treating pollutants in a biomedical tuberculosis ward according to this embodiment. DETAILED DESCRIPTION

[0080] In order to make the objects and advantages of the present invention more clearly understood, the present invention is further described below in conjunction with embodiments; it should be understood that the specific embodiments described herein are merely used to explain the present invention and are not intended to limit the present invention.

[0081] The preferred embodiments of the present invention are described below with reference to the accompanying drawings. It should be understood by those skilled in the art that these embodiments are only used to explain the technical principles of the present invention and are not intended to limit the scope of protection of the present invention.

[0082] It should be noted that, in the description of the present invention, terms such as "up", "down", "left", "right", "inside", and "outside" indicating directions or positional relationships are based on the directions or positional relationships shown in the accompanying drawings. This is only for the convenience of description and does not indicate or imply that the device or element must have a specific orientation, be constructed and operated in a specific orientation. Therefore, it cannot be understood as a limitation on the present invention.

[0083] Furthermore, it should be noted that, in the description of the present invention, unless otherwise expressly specified or limited, the terms "mounted," "connected," and "connected" should be understood in a broad sense. For example, they may refer to fixed connections, detachable connections, or integral connections; mechanical connections or electrical connections; direct connections or indirect connections through an intermediate medium; and internal communication between two components. Those skilled in the art will understand the specific meanings of the above terms in the present invention based on specific circumstances.

[0084] See also Figure 1 As shown in FIG, which is a schematic structural diagram of a device for treating pollutants in a biomedical tuberculosis ward in this example, the device comprises:

[0085] A breathing mask 1, which is connected to a telescopic arm 17 and is used to collect gas exhaled by the patient and perform aerosol treatment on the patient;

[0086] A system 2 for treating pollutants in a biomedical tuberculosis ward, connected to the device for treating pollutants in the biomedical tuberculosis ward and used to control the device for treating pollutants in the biomedical tuberculosis ward;

[0087] An exhaled gas transmission pipe 3, which is connected to the breathing mask 1 and the ultraviolet disinfection chamber 4, and is used to transmit the patient's exhaled gas to the ultraviolet disinfection chamber 4;

[0088] The ultraviolet disinfection chamber 4 is externally connected to the exhaled gas transmission pipe 3, the gas transmission pipe 5 and the plasma disinfection chamber 11, and is internally provided with a left wavy gas deflector 15 and a right wavy gas deflector 16 for ultraviolet disinfection of the patient's exhaled gas;

[0089] A gas transmission pipe 5 is connected to the ultraviolet disinfection chamber 4 and the plasma disinfection chamber 11, and is used to transmit the exhaust gas of the plasma disinfection chamber that does not meet the emission standards to the ultraviolet disinfection chamber 4;

[0090] an atomization pipe 6 connected to the breathing mask 1 and the ultrasonic atomizer 9, and used for transmitting the atomized medicine in the ultrasonic atomizer 9 to the breathing mask 1;

[0091] a drug storage tank 7 connected to a metering pump 8 for storing therapeutic drugs;

[0092] a metering pump 8 connected to the drug storage tank 7 and connected to the ultrasonic nebulizer 9 via a drug delivery pipe 18, for transferring the therapeutic drug from the drug storage tank 7 to the ultrasonic nebulizer 9;

[0093] Ultrasonic nebulizer 9, which is connected to metering pump 8 via drug delivery pipe 18 and connected to breathing mask 1 via atomization pipe 6, is used to atomize the therapeutic drug to obtain atomized drug;

[0094] A first plate-shaped gas deflector 10 is installed in the plasma disinfection chamber 11 and is used to drain the patient's exhaled gas entering the plasma disinfection chamber 11;

[0095] The plasma disinfection chamber 11 is connected to the ultraviolet disinfection chamber 4 and is used to perform plasma disinfection on the patient's exhaled gas;

[0096] A second plate-shaped gas guide plate 12 is installed in the plasma disinfection chamber 11 and is used to drain the patient's exhaled gas entering the plasma disinfection chamber 11;

[0097] A third plate-shaped gas guide plate 13 is installed in the plasma disinfection chamber 11 and is used to drain the patient's exhaled gas entering the plasma disinfection chamber 11;

[0098] An exhaust port 14 connected to the plasma disinfection chamber 11 for discharging gas that meets emission standards;

[0099] The left wavy gas deflector 15 is installed in the ultraviolet disinfection chamber 4 and is used to drain the patient's exhaled gas in the ultraviolet disinfection chamber 4;

[0100] The right wavy gas deflector 16 is installed in the ultraviolet disinfection chamber 4 and is used to drain the patient's exhaled gas in the ultraviolet disinfection chamber 4;

[0101] A robotic arm 17 connected to the breathing mask 1 and used to control the breathing mask 1 to reach the patient's face;

[0102] a drug delivery pipe 18 connected to the metering pump 8 and the ultrasonic atomizer 9 for delivering therapeutic drugs;

[0103] The discharge electrode and the insulating medium 19 are installed in the ultraviolet disinfection chamber 4 to generate low-temperature plasma, prevent short circuits between the electrodes, and adjust the electric field distribution;

[0104] The heating wire 20 is installed in the ultrasonic atomizer 9 and is used to control the temperature of the atomized medicine.

[0105] Specifically, the device is used in a tuberculosis ward. The device collects the patient's exhaled gas through a breathing mask 1, a telescopic arm 17 and a gas transmission pipe 3, and transmits it to the ultraviolet disinfection chamber 4. The left wavy gas deflector 15 and the right wavy gas deflector 16 in the ultraviolet disinfection chamber 4 guide the flow of the patient's exhaled gas to ensure that the gas is fully exposed to ultraviolet rays. At the same time, the discharge electrode and the insulating medium 19 in the ultraviolet disinfection chamber 4 generate low-temperature plasma to enhance the disinfection effect. The gas disinfected by the ultraviolet disinfection chamber 4 enters the plasma disinfection chamber 11 through the gas transmission pipe 5. The first plate-shaped gas deflector 10, the second plate-shaped gas deflector 12 and the plasma disinfection chamber 11 in the plasma disinfection chamber 11 The third plate-shaped gas guide plate 13 guides the flow of gas disinfected by the ultraviolet disinfection chamber 4, ensuring that the gas disinfected by the ultraviolet disinfection chamber 4 is fully exposed to the plasma for further disinfection. The gas that meets the emission standards and is disinfected by the ultraviolet disinfection chamber 4 and the plasma disinfection chamber 11 is discharged through the exhaust port 14. The device stores therapeutic drugs through the drug storage tank 7. At the same time, the metering pump 8 transmits the therapeutic drugs to the ultrasonic nebulizer 9 through the drug delivery pipe 18. The heating wire 20 in the ultrasonic nebulizer 9 regulates the temperature of the therapeutic drugs to ensure the atomization effect. The ultrasonic nebulizer 9 transmits the atomized therapeutic drugs to the breathing mask 1 through the atomization pipe 6 to perform atomization treatment on the patient. , wherein the device collects the patient's exhaled gas through the breathing mask 1 to ensure that the gas does not diffuse into the environment, and provides aerosol treatment to deliver medicine to the patient. The device safely transmits the patient's exhaled gas to the ultraviolet disinfection chamber 4 through the exhaled gas transmission pipeline to prevent gas leakage. The device performs ultraviolet disinfection through the ultraviolet disinfection chamber 4 to effectively kill pathogens in the exhaled gas, and ensures that the gas is evenly exposed to ultraviolet rays through the left wavy gas deflector 15 and the right wavy gas deflector 16 to improve the disinfection efficiency. The device performs plasma disinfection through the plasma disinfection chamber 11 to further kill pathogens that have not been completely treated by ultraviolet rays, and passes through the plate-shaped gas deflector 1 0, 12 and 13 ensure that the gas is evenly distributed in the cavity to improve the disinfection effect. The device atomizes the drug through the ultrasonic nebulizer 9 to facilitate patient inhalation and improve drug absorption efficiency. The device controls the drug delivery amount through the metering pump 8 to ensure the treatment effect. The device stores therapeutic drugs through the drug storage tank 7 to ensure drug stability and effectiveness. The device discharges standard gas through the exhaust port 14 to ensure environmental safety. The device generates low-temperature plasma through the discharge electrode and the insulating medium 19 to enhance the ultraviolet disinfection effect and prevent electrode short circuit to ensure safe operation of the equipment. The device regulates the drug temperature through the heating wire 20 to ensure the atomization effect and patient comfort.

[0106] Specifically, a preset number of high-intensity ultraviolet lamps with an emission wavelength of 253.7 nm are installed in the ultraviolet disinfection chamber 4. At the same time, a left wavy gas deflector 15 and a right wavy gas deflector 16 are provided in the ultraviolet disinfection chamber 4, so that the patient's exhaled gas forms a target flow path in the ultraviolet disinfection chamber 4.

[0107] Specifically, the high-intensity ultraviolet lamp refers to a light source that can emit high-intensity ultraviolet radiation for disinfection, sterilization and photochemical reactions. This embodiment does not limit the specific value of the preset number. Relevant technical personnel in this field can freely set it according to actual needs. It only needs to meet the needs of ultraviolet disinfection of the patient's exhaled gas. For example, the preset number can be set to 6.

[0108] Specifically, the capacity L of the medicine storage tank 7 ranges from 50ml to 200ml, and is provided with a transparent observation window.

[0109] Specifically, the capacity refers to the volume of the medicinal liquid that the medicine storage tank 7 can contain, and the transparent observation window refers to an observation window made of transparent and translucent materials, which allows the user to observe the medicinal liquid inside the medicine storage tank 7 without opening it.

[0110] Specifically, a voltage sensor is further provided in the plasma disinfection chamber 11 , and a Mycobacterium tuberculosis nucleic acid aptamer is provided on the surface of the voltage sensor. When the Mycobacterium tuberculosis nucleic acid aptamer binds to Mycobacterium tuberculosis, the voltage on the surface of the voltage sensor changes.

[0111] Specifically, the voltage sensor refers to an electronic device that detects and measures voltage signals in a circuit and converts them into readable outputs. The Mycobacterium tuberculosis nucleic acid aptamer refers to a specific target that can specifically recognize and bind to Mycobacterium tuberculosis. The Mycobacterium tuberculosis refers to the pathogen that causes tuberculosis.

[0112] Specifically, in the discharge electrode and the insulating medium 19, the discharge electrode is made of a metal material, molybdenum alloy, and an insulating medium is provided around the discharge electrode.

[0113] Specifically, the molybdenum alloy refers to an alloy material with molybdenum as the main component and metal elements such as titanium, zirconium, hafnium and rhenium added. The embodiment does not limit the specific number of insulating media. Relevant technicians in this field can freely set it according to actual needs. It only needs to meet the needs of plasma disinfection of the patient's exhaled gas. For example, the number of insulating media can be set to 8.

[0114] See also Figure 2 As shown in FIG, which is a schematic structural diagram of a system for treating pollutants in a biomedical tuberculosis ward according to this embodiment, the system includes:

[0115] An acquisition module collects operating data of the processing device;

[0116] A disinfection control module is used to adjust the plasma disinfection chamber according to the disinfection power of the plasma disinfection chamber and a preset minimum disinfection power and a preset maximum disinfection power; to calibrate the adjusted plasma disinfection chamber according to the concentration of pathogens entering the plasma disinfection chamber and a preset minimum pathogen concentration and a preset maximum pathogen concentration; to optimize the process of the calibrated and adjusted plasma disinfection chamber according to the patient's coughing frequency and a preset patient coughing frequency; to adjust the metering pump according to the concentration of each therapeutic drug and a preset therapeutic drug concentration; to correct the preset therapeutic drug concentration according to the patient's drug acceptance and a preset acceptance; and to regulate the heating wire according to the atomized drug temperature and a preset minimum atomized drug temperature and a preset maximum atomized drug temperature. The disinfection control module is connected to the acquisition module;

[0117] A treatment feedback module is used to output the concentration of pathogens entering the plasma disinfection chamber after a preset treatment time and the preset concentration of pathogens recovered by the patient's exhaled breath. The treatment feedback module is connected to the disinfection control module and the collection module;

[0118] The gas exhaust module is used to control the exhaust port according to the pathogen concentration of the gas discharged from the plasma disinfection chamber and the preset pathogen concentration of the gas discharged. The gas exhaust module is connected to the disinfection control module and the collection module.

[0119] Specifically, the system is applied to the pollutant treatment device of the biomedical tuberculosis ward. The system collects the operating data of the treatment device through the acquisition module and controls the pollutant treatment device of the biomedical tuberculosis ward through the disinfection control module. At the same time, the treatment feedback module outputs the actual treatment effect of the patient in real time. Finally, the system controls the exhaust port through the gas emission module to reduce the risk of infection. In particular, the system collects the operating data of the treatment device in real time through the acquisition module, provides data support for the disinfection control module, the treatment feedback module and the gas emission module, and ensures dynamic monitoring of the disinfection and treatment process. The system adjusts the disinfection power, corrects the disinfection power, optimizes the disinfection process, adjusts the therapeutic drug delivery amount of the metering pump, corrects the drug concentration setting, and regulates the working state of the heating wire through the disinfection control module to optimize the treatment process according to the specific situation of the patient, improve the treatment effect, and thus ensure the maximization of the disinfection effect and treatment effect. The system evaluates the treatment effect according to the change of pathogen concentration through the treatment feedback module, dynamically adjusts the treatment process, and realizes precision medicine. The system ensures that the pathogen concentration in the exhaust gas meets safety standards through the gas emission module to avoid environmental pollution.

[0120] Specifically, the acquisition module collects the operating data of the processing device, wherein the operating data of the processing device includes the disinfection power of the plasma disinfection chamber, the concentration of pathogens entering the plasma disinfection chamber, the patient's coughing frequency, the concentration of each therapeutic drug, the patient's drug acceptance, the temperature of the atomized drug, the concentration of pathogens entering the plasma disinfection chamber after a preset treatment time, and the concentration of pathogens in the gas discharged from the plasma disinfection chamber.

[0121] Specifically, this embodiment does not limit the method for collecting the operating data of the processing device. Relevant technicians in this field can freely set it according to actual needs, and only need to meet the needs of collecting the operating data of the processing device. For example, the operating data of the processing device can be collected by a sensor and retrogradely. The disinfection power of the plasma disinfection chamber refers to the electric power consumed by the plasma disinfection chamber when it is working. The concentration of pathogens entering the plasma disinfection chamber refers to the concentration of pathogens such as Mycobacterium tuberculosis in the exhaled gas of the patient entering the plasma disinfection chamber. The patient's cough frequency refers to the number of times the patient coughs per unit time. The concentration of each therapeutic drug refers to the concentration of various therapeutic drugs in the atomized drug. The patient's drug acceptance The degree refers to the patient's tolerance to the drug and the feedback on the treatment effect. The atomized drug temperature refers to the current temperature of the atomized drug. The pathogen concentration entering the plasma disinfection chamber after the preset treatment time refers to the concentration of pathogens in the patient's exhaled gas entering the plasma disinfection chamber after the preset treatment time. The pathogen concentration of the plasma disinfection chamber exhaust gas refers to the concentration of pathogens in the gas treated with plasma disinfection. The preset treatment time refers to the preset treatment cycle time. This embodiment does not limit the specific value of the preset treatment time. Relevant technicians in this field can freely set it according to actual needs, as long as it meets the need to judge the actual treatment effect of the patient. For example, the preset treatment time can be set to 3 days.

[0122] Specifically, the acquisition module covers data on disinfection, treatment and discharge, ensuring comprehensive monitoring of system operation and improving operational efficiency.

[0123] Specifically, the disinfection control module compares the disinfection power P of the plasma disinfection chamber with the preset minimum disinfection power P1 and the preset maximum disinfection power P2, judges the size of the disinfection power according to the comparison result, and adjusts the plasma disinfection chamber according to the judgment result, wherein:

[0124] P1=15W,P2=25W;

[0125] When P1≤P≤P2, it is determined that the plasma disinfection power is normal, and the plasma disinfection chamber is not controlled;

[0126] When P<P1, it is determined that the plasma disinfection power is too low, and the voltage U of the discharge electrode in the plasma disinfection chamber is adjusted, wherein the original voltage is U0, and the adjusted voltage is Up0min, Up0min=U0×(1+e （P / P1） );

[0127] When P>P2, it is determined that the plasma disinfection power is too high, and the voltage U of the discharge electrode in the plasma disinfection chamber is adjusted, wherein the original voltage is U0, and the adjusted voltage is Up0max, Up0max=U0×(1-e （P / P1） );

[0128] The disinfection control module compares the pathogen concentration L entering the plasma disinfection chamber with the preset minimum pathogen concentration L1 and the preset maximum pathogen concentration L2, judges the concentration of the pathogen entering the plasma disinfection chamber based on the comparison result, and calibrates the adjusted plasma disinfection chamber based on the judgment result, wherein:

[0129] L1=32 CFU / m 3 , L2=128CFU / m 3 ;

[0130] When L1≤L≤L2, it is determined that the concentration of the pathogens entering the plasma disinfection chamber is normal, and the adjusted plasma disinfection chamber is not corrected;

[0131] When L<L1, it is determined that the concentration of the pathogens entering the plasma disinfection chamber is low, and the adjusted plasma disinfection chamber is not corrected;

[0132] When L>L2, it is determined that the concentration of pathogens entering the plasma disinfection chamber is high. The adjusted plasma disinfection chamber is corrected by increasing the disinfection power P of the plasma disinfection chamber. The disinfection power of the corrected plasma disinfection chamber is set to PL, PL=0.82+e 0.5×[(L-L2)+18] ×P;

[0133] The disinfection control module compares the patient's cough frequency K with the preset patient cough frequency K0, judges the relationship between the patient's cough frequency and the concentration of pathogens entering the plasma disinfection chamber based on the comparison result, and optimizes the process of the calibrated and adjusted plasma disinfection chamber based on the judgment result, wherein:

[0134] When K≤K0, the relationship between the patient's cough frequency and the pathogen concentration is determined to be low frequency, which does not affect the concentration of pathogens entering the plasma disinfection chamber, and the process of the plasma disinfection chamber after calibration and adjustment is not optimized;

[0135] When K>K0, the relationship between the patient's cough frequency and the pathogen concentration is determined to be high frequency, the pathogen concentration entering the plasma disinfection chamber is increased, and the pathogen concentration L in the plasma disinfection chamber after correction and adjustment is optimized. The optimized pathogen concentration is set as Lk, Lk=[0.77+e 0.62×[(K-K0)+3] ]×L;

[0136] The disinfection control module compares the concentrations of each therapeutic drug Y1, Y2, Y3, ..., Yn with the preset concentrations of each therapeutic drug Y01, Y02, Y03, ..., Y0n, judges whether the concentration of each therapeutic drug meets the standard based on the comparison results, and adjusts the metering pump based on the judgment results, wherein:

[0137] When Y1<Y10, it is determined that the concentration of the therapeutic drug is too low, and the volume Vy1 of the therapeutic drug delivered each time by the metering pump is adjusted to Vminy1, where Vminy1=1.5×Vy1;

[0138] When Y1=Y10, the concentration of the therapeutic drug is determined to be appropriate and the metering pump is not adjusted;

[0139] When Y1>Y10, it is determined that the concentration of the therapeutic drug is too high, and the volume Vy1 of the therapeutic drug delivered each time by the metering pump is adjusted to Vmaxy1, where Vmaxy1=0.5×Vy1;

[0140] When Y2<Y20, it is determined that the concentration of the therapeutic drug is too low, and the volume Vy2 of the therapeutic drug delivered each time by the metering pump is adjusted to Vminy2, where Vminy2=1.5×Vy2;

[0141] When Y2=Y20, the concentration of the therapeutic drug is determined to be appropriate and the metering pump is not adjusted;

[0142] When Y2>Y20, it is determined that the concentration of the therapeutic drug is too high, and the volume Vy2 of the therapeutic drug delivered each time by the metering pump is adjusted to Vmaxy2, where Vmaxy2=0.5×Vy2;

[0143] When Y3<Y30, it is determined that the concentration of the therapeutic drug is too low, and the volume Vy3 of the therapeutic drug delivered each time by the metering pump is adjusted to Vminy3, where Vminy3=1.5×Vy3;

[0144] When Y3=Y30, the concentration of the therapeutic drug is determined to be appropriate and the metering pump is not adjusted;

[0145] When Y3>Y30, it is determined that the concentration of the therapeutic drug is too high, and the volume Vy3 of the therapeutic drug delivered each time by the metering pump is adjusted to Vmaxy3, where Vmaxy3=0.5×Vy3;

[0146] …

[0147] When Yn<Yn0, it is determined that the concentration of the therapeutic drug is too low, and the volume Vyn of the therapeutic drug delivered each time by the metering pump is adjusted to Vminyn, where Vminyn=1.5×Vyn;

[0148] When Yn=Yn0, the concentration of the therapeutic drug is determined to be appropriate and the metering pump is not adjusted;

[0149] When Yn>Yn0, the concentration of the therapeutic drug is determined to be too high, and the volume Vyn of the therapeutic drug delivered each time by the metering pump is adjusted to Vmaxyn, where Vmaxyn=0.5×Vyn;

[0150] The disinfection control module compares the patient's drug acceptance J with the preset acceptance J0, judges the patient's treatment effect based on the comparison result, and corrects the preset concentrations of each therapeutic drug based on the judgment result, wherein:

[0151] When J≥J0, the patient's treatment effect is determined to be satisfactory, and no correction is made to the preset concentrations of the therapeutic drugs;

[0152] When J<J0, the patient's treatment effect is determined to be substandard, and the preset concentrations of each therapeutic drug are corrected. The corrected preset concentrations of each therapeutic drug are set as Yj01, Yj02, Yj03, ..., Yj0n, and the calculation formulas are Yj01=1.68e J-J0 +2J+Y01、Yj02=1.68e J-J0 +2J+Y02、Yj03=1.68e J-J0 +2J+Y03、……、Yj0n=1.68e J-J0 +2J+Y0n;

[0153] The disinfection control module compares the atomized drug temperature W with the preset minimum atomized drug temperature W1 and the preset maximum atomized drug temperature W2, judges the credibility of the patient's drug acceptance based on the comparison results, and regulates the heating wire based on the judgment results, wherein:

[0154] When W1≤W≤W2, the credibility of the patient's drug acceptance is determined to be up to standard, and the heating wire is not regulated;

[0155] When W<W1, it is determined that the credibility of the patient's drug acceptance does not meet the standard, and the heating wire is adjusted to increase the atomized drug temperature W until the credibility of the patient's drug acceptance meets the standard;

[0156] When W>W2, it is determined that the reliability of the patient's drug acceptance does not meet the standard, and the heating wire is regulated to reduce the atomized drug temperature W until the reliability of the patient's drug acceptance meets the standard.

[0157] Specifically, the preset disinfection minimum power P1 refers to the minimum power value set during the plasma disinfection process, the preset disinfection maximum power P2 refers to the maximum power value set during the plasma disinfection process, the original voltage U0 refers to the reference voltage value of the discharge electrode in the plasma disinfection chamber before adjustment, and this embodiment does not limit the specific value of the original voltage U0. For example, the original voltage U0 can be set to 36V. The preset minimum pathogen concentration L1 refers to the lowest acceptable pathogen concentration in the air entering the plasma disinfection chamber, and the preset maximum pathogen concentration L2 refers to the highest acceptable pathogen concentration in the air entering the plasma disinfection chamber. The preset patient cough frequency K0 refers to the reference value of the patient's cough frequency. This embodiment does not limit the specific value of the cough frequency K0. For example, the cough frequency K0 can be set to 3 times / minute. The preset therapeutic drug concentrations Y01, Y02, Y03, ... Y0n refer to the standard concentration values ​​of each therapeutic drug. This embodiment does not set the therapeutic drug concentrations Y0 1. The specific types and values ​​of Y02, Y03, ..., Y0n are limited. For example, isoniazid can be set as Y01, and its standard concentration value is 50-200 mg / mL, rifampicin can be set as Y02, and its standard concentration value is 10-00 mg / mL, streptomycin can be set as Y03, and its standard concentration value is 25-100 mg / mL, ..., ambroxol can be set as Y0n, and its standard concentration value is 15-30 mg / mL. The preset acceptance J0 refers to the patient's baseline acceptance of drug treatment. This embodiment does not set the preset acceptance J0. The specific value of 0 is limited, such as the preset acceptance J0=0.65, the preset minimum atomized drug temperature W1 refers to the lower limit of the temperature of the atomized drug, and the present embodiment does not limit the specific value of the preset minimum atomized drug temperature W1, such as the preset minimum atomized drug temperature W1=35°C, the preset maximum atomized drug temperature W2 refers to the upper limit of the temperature of the atomized drug, and the present embodiment does not limit the specific value of the preset maximum atomized drug temperature W2, such as the preset maximum atomized drug temperature W2=38°C.

[0158] Specifically, the disinfection control module monitors the disinfection power P and compares it with the preset power range, automatically adjusts the voltage of the discharge electrode, ensures that the disinfection process is carried out within a safe and effective power range, prevents insufficient disinfection effect or equipment damage, judges the disinfection needs by monitoring the pathogen concentration L, and automatically adjusts the disinfection power to keep the indoor air quality within a safe range, thereby effectively controlling the infection risk, and combines the patient's cough frequency K to judge the impact of coughing on the pathogen concentration, further optimizes the disinfection process to cope with potential increases in pathogen concentrations, and ensures that the disinfection effect is sustained and effective. By comparing the actual drug concentration with the preset standard concentration, the delivery volume of the metering pump is automatically adjusted to ensure that the drug concentration is always within the optimal treatment range, thereby improving the treatment effect. According to the patient's drug acceptance J, the drug concentration is adjusted to provide a personalized treatment plan to achieve the best treatment effect. By adjusting the temperature of the atomized drug to ensure that it is within the preset temperature range, the drug acceptance and treatment comfort are improved, which helps to improve the patient's treatment quality and safety.

[0159] Specifically, the treatment feedback module compares the pathogen concentration L0 entering the plasma disinfection chamber after the preset treatment time with the preset patient recovery exhaled pathogen concentration L03, judges the actual treatment situation of the patient based on the comparison result, and outputs the judgment result, wherein:

[0160] When L=0, the actual treatment situation of the patient is judged to be that the actual exhaled pathogen concentration of the patient is 0, the patient has been successfully cured, and the output is the end of treatment;

[0161] When L≤L03, the actual treatment situation of the patient is judged to be that the concentration of pathogens actually exhaled by the patient is reduced, the patient's condition is alleviated, and the output is to maintain treatment;

[0162] When L>L03, it is determined that the actual treatment situation of the patient is that the concentration of pathogens actually exhaled by the patient increases and the patient's condition worsens. The output is to adjust the time the patient wears the breathing mask. The original time the patient wears the breathing mask is set to T0, and the adjusted time the patient wears the breathing mask is T0`, T0`=T0+(L-L03) / L.

[0163] Specifically, the preset patient recovery exhaled pathogen concentration L03 refers to the target value of the pathogen concentration in the patient's exhaled air expected during the patient's recovery process. This embodiment does not limit the specific numerical value of the preset patient recovery exhaled pathogen concentration L03. Relevant technical personnel in this field can freely set it according to actual needs, and only need to meet the needs of judging the actual situation of the patient's treatment. For example, the preset patient recovery exhaled pathogen concentration L03 can be set to 16 CFU / m3. The patient's original breathing mask wearing time refers to the standard length of time set for the patient to wear a breathing mask at the beginning of treatment. This embodiment does not limit the specific numerical value of the patient's original breathing mask wearing time. For example, the patient's original breathing mask wearing time can be set to 8 hours / day.

[0164] Specifically, the treatment feedback module determines the patient's recovery status by real-time monitoring of pathogen concentration to ensure the effectiveness of treatment, and adjusts the wearing time of the respiratory mask to prevent the disease from worsening and ensure the safety of the patient.

[0165] Specifically, the gas exhaust module compares the pathogen concentration Lp of the gas discharged from the plasma disinfection chamber with the preset pathogen concentration Lp0 of the gas discharged, judges whether the pathogen concentration Lp of the gas discharged from the plasma disinfection chamber meets the emission standard based on the comparison result, and controls the exhaust port based on the judgment result, wherein:

[0166] When Lp≤Lp0, it is determined that the pathogen concentration Lp of the gas discharged from the plasma disinfection chamber reaches the emission standard, and the gas emission module controls the exhaust port to open to discharge the gas discharged from the plasma disinfection chamber;

[0167] When Lp>Lp0, it is determined that the pathogen concentration Lp of the plasma disinfection chamber exhaust gas does not meet the emission standard, and the gas exhaust module controls the exhaust port to be closed, and re-transmits the plasma disinfection chamber exhaust gas to the ultraviolet disinfection chamber for disinfection.

[0168] Specifically, the preset exhaust gas pathogen concentration Lp0 refers to the concentration value of pathogens allowed to be contained in the exhaust gas of the plasma disinfection chamber. This embodiment does not limit the specific value of the preset exhaust gas pathogen concentration Lp0. Relevant technicians in this field can freely set it according to actual needs. It only needs to meet the need of judging whether the exhaust gas pathogen concentration Lp of the plasma disinfection chamber meets the emission standard. For example, the preset exhaust gas pathogen concentration Lp0 can be set to 0.01 CFU / m3.

[0169] Specifically, the gas emission module monitors the pathogen concentration in the exhaust gas in real time to ensure that only gases that meet safety standards are emitted, thereby reducing potential risks to the environment and human health.

[0170] Thus far, the technical solutions of the present invention have been described in conjunction with the preferred embodiments shown in the accompanying drawings. However, it will be readily understood by those skilled in the art that the scope of protection of the present invention is obviously not limited to these specific embodiments. Without departing from the principles of the present invention, those skilled in the art may make equivalent changes or substitutions to the relevant technical features, and the technical solutions after such changes or substitutions will fall within the scope of protection of the present invention.

Claims

1. A system for treating pollutants in a biomedical tuberculosis ward, which is applied to a device for treating pollutants in a biomedical tuberculosis ward, characterized in that: The device for treating pollutants in a biomedical tuberculosis ward comprises: A breathing mask connected to a telescopic arm for collecting gas exhaled by the patient and performing aerosol treatment on the patient; A system for treating pollutants in a biomedical tuberculosis ward, which is connected to a device for treating pollutants in a biomedical tuberculosis ward and is used to control the device for treating pollutants in the biomedical tuberculosis ward; An exhaled gas transmission pipeline is connected to the breathing mask and the ultraviolet disinfection chamber and is used to transmit the patient's exhaled gas to the ultraviolet disinfection chamber; The ultraviolet disinfection chamber is externally connected to the exhaled gas transmission pipeline, the gas transmission pipeline and the plasma disinfection chamber, and is internally provided with a left wavy gas guide plate and a right wavy gas guide plate for ultraviolet disinfection of the patient's exhaled gas; A gas transmission pipeline is connected to the ultraviolet disinfection chamber and the plasma disinfection chamber, and is used to transmit the exhaust gas from the plasma disinfection chamber that does not meet the emission standards to the ultraviolet disinfection chamber; an atomization pipe connected to the breathing mask and the ultrasonic nebulizer, and used for transmitting the atomized medicine in the ultrasonic nebulizer to the breathing mask; a drug storage tank connected to the metering pump and used to store therapeutic drugs; a metering pump connected to the drug storage tank and connected to the ultrasonic nebulizer through a drug delivery pipeline, for transferring the therapeutic drug from the drug storage tank to the ultrasonic nebulizer; An ultrasonic nebulizer is connected to a metering pump via a drug delivery pipe and to a breathing mask via an atomization pipe, and is used to atomize therapeutic drugs to obtain aerosolized drugs; a first plate-shaped gas guide plate, which is installed in the plasma disinfection chamber and is used to drain the patient's exhaled gas entering the plasma disinfection chamber; The plasma disinfection chamber is connected to the ultraviolet disinfection chamber and is used to perform plasma disinfection on the patient's exhaled gas; a second plate-shaped gas guide plate, which is installed in the plasma disinfection chamber and is used to drain the patient's exhaled gas entering the plasma disinfection chamber; a third plate-shaped gas guide plate, which is installed in the plasma disinfection chamber and is used to drain the patient's exhaled gas entering the plasma disinfection chamber; An exhaust port, connected to the plasma disinfection chamber, for discharging gas that meets emission standards; The left wavy gas deflector is installed in the ultraviolet disinfection chamber and is used to drain the patient's exhaled gas in the ultraviolet disinfection chamber; The right wavy gas deflector is installed in the ultraviolet disinfection chamber and is used to drain the patient's exhaled gas in the ultraviolet disinfection chamber; a robotic arm connected to the breathing mask and used to control the breathing mask to reach the patient's face; a drug delivery pipeline connected to a metering pump and an ultrasonic nebulizer for delivering therapeutic drugs; Discharge electrodes and insulating medium, which are installed in the ultraviolet disinfection chamber, are used to generate low-temperature plasma, prevent short circuits between electrodes, and adjust electric field distribution; A heating wire is installed in the ultrasonic nebulizer to control the temperature of the atomized drug; The system for treating pollutants in a biomedical tuberculosis ward comprises: An acquisition module collects operating data of the processing device; a disinfection control module for adjusting the plasma disinfection chamber according to the disinfection power of the plasma disinfection chamber and a preset minimum disinfection power and a preset maximum disinfection power; calibrating the adjusted plasma disinfection chamber according to the concentration of pathogens entering the plasma disinfection chamber and a preset minimum pathogen concentration and a preset maximum pathogen concentration; optimizing the process of the calibrated and adjusted plasma disinfection chamber according to the patient's coughing frequency and a preset patient coughing frequency; adjusting the metering pump according to the concentration of each therapeutic drug and a preset therapeutic drug concentration; correcting the preset therapeutic drug concentration according to the patient's drug acceptance and a preset acceptance; and regulating the heating wire according to the atomized drug temperature and a preset minimum atomized drug temperature and a preset maximum atomized drug temperature; A treatment feedback module is used to output the concentration of pathogens entering the plasma disinfection chamber after a preset treatment time and the preset concentration of pathogens recovered by the patient in the exhaled air; A gas exhaust module is used to control the exhaust port according to the pathogen concentration of the gas discharged from the plasma disinfection chamber and the preset pathogen concentration of the gas discharged; The disinfection control module compares the disinfection power P of the plasma disinfection chamber with the preset minimum disinfection power P1 and the preset maximum disinfection power P2, judges the size of the disinfection power according to the comparison result, and adjusts the plasma disinfection chamber according to the judgment result, wherein: P1=15W,P2=25W; When P1≤P≤P2, it is determined that the plasma disinfection power is normal, and the plasma disinfection chamber is not controlled; When P<P1, it is determined that the plasma disinfection power is too low, and the voltage U of the discharge electrode in the plasma disinfection chamber is adjusted, wherein the original voltage is U0, and the adjusted voltage is Up0min, Up0min=U0×(1+e （P / P1） ); When P>P2, it is determined that the plasma disinfection power is too high, and the voltage U of the discharge electrode in the plasma disinfection chamber is adjusted, wherein the original voltage is U0, and the adjusted voltage is Up0max, Up0max=U0×(1-e （P / P1） ).

2. The system for treating pollutants in a biomedical tuberculosis ward according to claim 1, characterized in that: The disinfection control module compares the pathogen concentration L entering the plasma disinfection chamber with the preset minimum pathogen concentration L1 and the preset maximum pathogen concentration L2, judges the concentration of the pathogen entering the plasma disinfection chamber based on the comparison result, and calibrates the adjusted plasma disinfection chamber based on the judgment result, wherein: L1=32CFU / m 3 ,L2=128CFU / m 3 ; When L1≤L≤L2, it is determined that the concentration of the pathogens entering the plasma disinfection chamber is normal, and the adjusted plasma disinfection chamber is not corrected; When L<L1, it is determined that the concentration of the pathogens entering the plasma disinfection chamber is low, and the adjusted plasma disinfection chamber is not corrected; When L>L2, it is determined that the concentration of pathogens entering the plasma disinfection chamber is high. The adjusted plasma disinfection chamber is corrected by increasing the disinfection power P of the plasma disinfection chamber. The disinfection power of the corrected plasma disinfection chamber is set to PL, PL=0.82+e 0.5×[(L-L2)+18] ×P.

3. The system for treating pollutants in a biomedical tuberculosis ward according to claim 2, characterized in that: The disinfection control module compares the patient's cough frequency K with the preset patient cough frequency K0, judges the relationship between the patient's cough frequency and the concentration of pathogens entering the plasma disinfection chamber based on the comparison result, and optimizes the process of the calibrated and adjusted plasma disinfection chamber based on the judgment result, wherein: When K≤K0, the relationship between the patient's cough frequency and the pathogen concentration is determined to be low frequency, which does not affect the concentration of pathogens entering the plasma disinfection chamber, and the process of the plasma disinfection chamber after calibration and adjustment is not optimized; When K>K0, the relationship between the patient's cough frequency and the pathogen concentration is determined to be high frequency, the pathogen concentration entering the plasma disinfection chamber is increased, and the pathogen concentration L in the plasma disinfection chamber after correction and adjustment is optimized. The optimized pathogen concentration is set as Lk, Lk=[0.77+e 0.62×[(K-K0)+3] ]×L.

4. The system for treating pollutants in a biomedical tuberculosis ward according to claim 3, characterized in that: The disinfection control module compares the concentrations of each therapeutic drug Y1, Y2, Y3, ..., Yn with the preset concentrations of each therapeutic drug Y01, Y02, Y03, ..., Y0n, judges whether the concentration of each therapeutic drug meets the standard based on the comparison results, and adjusts the metering pump based on the judgment results, wherein: When Y1<Y10, it is determined that the concentration of the therapeutic drug is too low, and the volume Vy1 of the therapeutic drug delivered each time by the metering pump is adjusted to Vminy1, where Vminy1=1.5×Vy1; When Y1=Y10, the concentration of the therapeutic drug is determined to be appropriate and the metering pump is not adjusted; When Y1>Y10, it is determined that the concentration of the therapeutic drug is too high, and the volume Vy1 of the therapeutic drug delivered each time by the metering pump is adjusted to Vmaxy1, where Vmaxy1=0.5×Vy1; When Y2<Y20, it is determined that the concentration of the therapeutic drug is too low, and the volume Vy2 of the therapeutic drug delivered each time by the metering pump is adjusted to Vminy2, where Vminy2=1.5×Vy2; When Y2=Y20, the concentration of the therapeutic drug is determined to be appropriate and the metering pump is not adjusted; When Y2>Y20, it is determined that the concentration of the therapeutic drug is too high, and the volume Vy2 of the therapeutic drug delivered each time by the metering pump is adjusted to Vmaxy2, where Vmaxy2=0.5×Vy2; When Y3<Y30, it is determined that the concentration of the therapeutic drug is too low, and the volume Vy3 of the therapeutic drug delivered each time by the metering pump is adjusted to Vminy3, where Vminy3=1.5×Vy3; When Y3=Y30, the concentration of the therapeutic drug is determined to be appropriate and the metering pump is not adjusted; When Y3>Y30, it is determined that the concentration of the therapeutic drug is too high, and the volume Vy3 of the therapeutic drug delivered each time by the metering pump is adjusted to Vmaxy3, where Vmaxy3=0.5×Vy3; …… When Yn<Yn0, it is determined that the concentration of the therapeutic drug is too low, and the volume Vyn of the therapeutic drug delivered each time by the metering pump is adjusted to Vminyn, where Vminyn=1.5×Vyn; When Yn=Yn0, the concentration of the therapeutic drug is determined to be appropriate and the metering pump is not adjusted; When Yn>Yn0, it is determined that the concentration of the therapeutic drug is too high, and the volume Vyn of the therapeutic drug delivered each time by the metering pump is adjusted to Vmaxyn, where Vmaxyn=0.5×Vyn.

5. The system for treating pollutants in a biomedical tuberculosis ward according to claim 4, characterized in that: The disinfection control module compares the patient's drug acceptance J with the preset acceptance J0, judges the patient's treatment effect based on the comparison result, and corrects the preset concentrations of each therapeutic drug based on the judgment result, wherein: When J≥J0, the patient's treatment effect is determined to be satisfactory, and no correction is made to the preset concentrations of the therapeutic drugs; When J<J0, the patient's treatment effect is determined to be substandard, and the preset concentrations of each therapeutic drug are corrected. The corrected preset concentrations of each therapeutic drug are set as Yj01, Yj02, Yj03, ..., Yj0n, and the calculation formulas are Yj01=1.68e J-J0 +2J+Y01、Yj02=1.68e J-J0 +2J+Y02、Yj03=1.68e J-J0 +2J+Y03、……、Yj0n=1.68e J-J0 +2J+Y0n.

6. The system for treating pollutants in a biomedical tuberculosis ward according to claim 5, characterized in that: The disinfection control module compares the atomized drug temperature W with the preset minimum atomized drug temperature W1 and the preset maximum atomized drug temperature W2, judges the credibility of the patient's drug acceptance based on the comparison results, and regulates the heating wire based on the judgment results, wherein: When W1≤W≤W2, the credibility of the patient's drug acceptance is determined to be up to standard, and the heating wire is not regulated; When W<W1, it is determined that the credibility of the patient's drug acceptance does not meet the standard, and the heating wire is adjusted to increase the atomized drug temperature W until the credibility of the patient's drug acceptance meets the standard; When W>W2, it is determined that the reliability of the patient's drug acceptance does not meet the standard, and the heating wire is regulated to reduce the atomized drug temperature W until the reliability of the patient's drug acceptance meets the standard.

7. The system for treating pollutants in a biomedical tuberculosis ward according to claim 1, characterized in that: The treatment feedback module compares the pathogen concentration L0 entering the plasma disinfection chamber after the preset treatment time with the preset patient recovery exhaled pathogen concentration L03, judges the actual treatment situation of the patient based on the comparison result, and outputs the judgment result, wherein: When L=0, the actual treatment situation of the patient is judged to be that the actual exhaled pathogen concentration of the patient is 0, the patient has been successfully cured, and the output is the end of treatment; When L≤L03, the actual treatment situation of the patient is judged to be a decrease in the concentration of pathogens actually exhaled by the patient, and the patient's condition is alleviated, and the output is to maintain treatment; When L>L03, it is determined that the actual treatment situation of the patient is that the concentration of pathogens actually exhaled by the patient increases and the patient's condition worsens. The output is to adjust the time the patient wears the breathing mask. The original time the patient wears the breathing mask is set to T0, and the adjusted time the patient wears the breathing mask is T0`, T0`=T0+(L-L03) / L.

8. The system for treating pollutants in a biomedical tuberculosis ward according to claim 1, characterized in that: The gas exhaust module compares the pathogen concentration Lp of the gas discharged from the plasma disinfection chamber with the preset pathogen concentration Lp0 of the gas discharged, judges whether the pathogen concentration Lp of the gas discharged from the plasma disinfection chamber meets the emission standard based on the comparison result, and controls the exhaust port based on the judgment result, wherein: When Lp≤Lp0, it is determined that the pathogen concentration Lp of the gas discharged from the plasma disinfection chamber reaches the emission standard, and the gas emission module controls the exhaust port to open to discharge the gas discharged from the plasma disinfection chamber; When Lp>Lp0, it is determined that the pathogen concentration Lp of the plasma disinfection chamber exhaust gas does not meet the emission standard, and the gas exhaust module controls the exhaust port to be closed, and re-transmits the plasma disinfection chamber exhaust gas to the ultraviolet disinfection chamber for disinfection.

Images